NPPA fixes retail prices of 71 formulations including Empagliflozin, Metformin, Sitagliptin and Glimepiride Ruchika Sharma8 July 2025 5:45 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 71 formulations under Drugs (Prices Control) Order,...
Empagliflozin Not Linked to Increased Risk of Urinary Tract Cancers: Study Dr Riya Dave26 Jun 2025 8:15 PM ISTEmpagliflozin use in patients with type 2 diabetes (T2D) has not been shown to have a higher risk of urinary tract cancers (UTCs), such as bladder and...
Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Bayer Ruchika Sharma9 Jun 2025 10:00 AM ISTBerlin: Bayer has announced results of the Phase II CONFIDENCE study, demonstrating that simultaneous initiation of finerenone (Kerendia)...
Finerenone and Empagliflozin Combo Significantly Reduces Albuminuria in CKD with T2D: new data from CONFIDENCE Trial Dr. Kamal Kant Kohli6 Jun 2025 9:00 PM ISTNew findings from the CONFIDENCE trial show that combination therapy with finerenone and empagliflozin leads to significantly greater reductions in...
Micro Labs Launches Sitanorm-E, Sitagliptin-Empagliflozin FDC for Uncontrolled Type 2 Diabetes in India Deeksha Bhandari6 Jun 2025 12:11 PM ISTMicro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin. The combination is formulated to...
NPPA sets retail prices for 41 drugs, including 29 Fixed-Dose Combinations containing Empagliflozin or Sitagliptin Ruchika Sharma5 Jun 2025 4:05 PM ISTNew Delhi: In its 133rd meeting held on May 29, 2025, the National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 41...
CDSCO Panel Clears Abbott's Phase IV Trial for Empagliflozin + Metformin FDC, Seeks More Sites Dr. Divya Colin26 May 2025 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Abbott Healthcare...
Micro Labs Launches Sitanorm E: Sitagliptin + Empagliflozin FDC for diabetes patients in India Deeksha Bhandari26 May 2025 11:40 AM ISTMicro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin for the management of ...
Zydus Told to Withdraw Unmarketed Strengths, Conduct Phase IV Trial for Approved Combinations Only Dr. Divya Colin23 May 2025 9:44 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus Healthcare Ltd. to...
What is effect of Empagliflozin on Thyroid Hormones in prediabetics and diabetes patients? Jacinthlyn Sylvia15 May 2025 9:30 AM ISTThis study from Kerman University of Medical Sciences have that empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor used to treat type 2...
NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
